Describe and discuss the use of WGS for the routine detection and monitoring of antimicrobial resistance of pathogens of clinical importance.
Detection of Resistance-associated Mutations in Cytomegalovirus Through the Use of Next-generation
Sequencing
Matthew Binnicker, PhD, Mayo Clinic, Rochester, MN, USA
Clinical Whole-genome Sequencing and Drug Resistance Reporting for mycobacterium tuberculosis in
New York: A 5 Year Summary
Kimberlee Musser, PhD, Wadsworth Center, New York Department of Health, Wadsworth Center, Loudonville,
NY, USA
Objectives:
- Understand the basic design of a Next generation sequencing (NGS) whole-genome sequencing (WGS)
approach to detect mutations of clinical significance.
- Discuss the application of next-generation sequencing for the detection and identification of resistance-associated mutations for Mycobacterium tuberculosis and cytomegalovirus.
- Be familiar with interpretation and reporting of NGS WGS testing.
Recording Date: November 20, 2020
Continuing Education Credit Information
CME/CMLE credit: 1.50 hr
Last day to purchase course and CE claim credit: February 16, 2024
Note: Members of AMP can access this at a discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
